Erste Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30,000
Closed -$294K 774
2025
Q2
$296K Buy
+30,000
New +$309K ﹤0.01% 713
2024
Q4
Sell
-670
Closed -$10.9K 564
2024
Q3
$12.8K Hold
670
﹤0.01% 532
2024
Q2
$13.8K Hold
670
﹤0.01% 530
2024
Q1
$12.1K Hold
670
﹤0.01% 526
2023
Q4
$9.62K Hold
670
﹤0.01% 536
2023
Q3
$11.1K Hold
670
﹤0.01% 535
2023
Q2
$13.7K Hold
670
﹤0.01% 560
2023
Q1
$15.2K Hold
670
﹤0.01% 572
2022
Q4
$18.5K Sell
670
-13
-2% -$332 ﹤0.01% 555
2022
Q3
$16.7K Sell
683
-60
-8% -$1.81K ﹤0.01% 543
2022
Q2
$25.8K Sell
743
-808
-52% -$28.3K ﹤0.01% 555
2022
Q1
$55.1K Hold
1,551
﹤0.01% 531
2021
Q4
$46.4K Sell
1,551
-994
-39% -$32.4K ﹤0.01% 518
2021
Q3
$85.5K Sell
2,545
-1,933
-43% -$61.8K ﹤0.01% 486
2021
Q2
$137K Buy
+4,478
New +$147K ﹤0.01% 475

Other funds holding OGN

Erste Asset Management's OGN Position: Q3 2025 in Review

Erste Asset Management sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 30,000 shares — an estimated $294K sold.

Erste Asset Management first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $296K in Q2 2025. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Erste Asset Management reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Erste Asset Management sold 30,000 Organon & Co shares in Q3 2025, an estimated $294K.
  • Erste Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
  • Erste Asset Management's Organon & Co position peaked at $296K in Q2 2025.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Erste Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.